TILCURE Trademark

Trademark Overview

On Monday, June 27, 2016, a trademark application was filed for TILCURE with the United States Patent and Trademark Office. The USPTO has given the TILCURE trademark a serial number of 79193659. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The TILCURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of melanoma
tilcure

General Information

Serial Number79193659
Word MarkTILCURE
Filing DateMonday, June 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158557
Registration DateTuesday, March 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of melanoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFR

Trademark Events

Event DateEvent Description
Saturday, October 22, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 17, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2016ASSIGNED TO EXAMINER
Friday, October 21, 2016NON-FINAL ACTION WRITTEN
Saturday, October 22, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 25, 2016REFUSAL PROCESSED BY MPU
Tuesday, October 25, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 10, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 10, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 11, 2016REFUSAL PROCESSED BY IB
Monday, November 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 23, 2017GENERIC MADRID TRANSACTION CREATED
Friday, June 23, 2017GENERIC MADRID TRANSACTION SENT TO IB
Friday, August 18, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Saturday, April 10, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, March 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 29, 2023CANCELLED SECTION 71
Saturday, May 4, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 29, 2024GENERIC MADRID TRANSACTION SENT TO IB
Saturday, June 29, 2024GENERIC MADRID TRANSACTION CREATED

Related Keywords

tilcure melanoma treatment products pharmaceutical